{"id":"https://openalex.org/W4281487869","doi":"https://doi.org/10.1021/acs.molpharmaceut.2c00112","title":"iBCS: 2. Mechanistic Modeling of Pulmonary Availability of Inhaled Drugs versus Critical Product Attributes","display_name":"iBCS: 2. Mechanistic Modeling of Pulmonary Availability of Inhaled Drugs versus Critical Product Attributes","publication_year":2022,"publication_date":"2022-05-24","ids":{"openalex":"https://openalex.org/W4281487869","doi":"https://doi.org/10.1021/acs.molpharmaceut.2c00112","pmid":"https://pubmed.ncbi.nlm.nih.gov/35609877","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9257747"},"language":"en","primary_location":{"id":"doi:10.1021/acs.molpharmaceut.2c00112","doi":"https://doi.org/10.1021/acs.molpharmaceut.2c00112","is_oa":true,"landing_page_url":"https://doi.org/10.1021/acs.molpharmaceut.2c00112","pdf_url":null,"source":{"id":"https://openalex.org/S204562082","display_name":"Molecular Pharmaceutics","issn_l":"1543-8384","issn":["1543-8384","1543-8392"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmaceutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1021/acs.molpharmaceut.2c00112","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081409383","display_name":"Per B\u00e4ckman","orcid":"https://orcid.org/0000-0001-6210-8461","observed_orcids":["https://orcid.org/0000-0001-6210-8461"]},"institutions":[{"id":"https://openalex.org/I4210088933","display_name":"Medicon Village","ror":"https://ror.org/00a1grh69","country_code":"SE","type":"other","lineage":["https://openalex.org/I4210088933"]}],"countries":["SE"],"is_corresponding":true,"raw_author_name":"Per B\u00e4ckman","raw_affiliation_strings":["Emmace Consulting AB, Medicon Village, Scheelev\u00e4gen\r2, Lund SE-223 81, Sweden"],"raw_orcid":"https://orcid.org/0000-0001-6210-8461","affiliations":[{"raw_affiliation_string":"Emmace Consulting AB, Medicon Village, Scheelev\u00e4gen\r2, Lund SE-223 81, Sweden","institution_ids":["https://openalex.org/I4210088933"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063033406","display_name":"Antonio Cabal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151718","display_name":"Eisai (United States)","ror":"https://ror.org/0469x1750","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151718","https://openalex.org/I55881946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Antonio Cabal","raw_affiliation_strings":["Eisai, Woodcliff Lake, New Jersey 07677, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai, Woodcliff Lake, New Jersey 07677, United States","institution_ids":["https://openalex.org/I4210151718"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Andy Clark","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andy Clark","raw_affiliation_strings":["Aerogen Pharma, San Mateo, California 94402, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aerogen Pharma, San Mateo, California 94402, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046196564","display_name":"Carsten Ehrhardt","orcid":"https://orcid.org/0000-0003-0730-1829","observed_orcids":["https://orcid.org/0000-0003-0730-1829"]},"institutions":[{"id":"https://openalex.org/I205274468","display_name":"Trinity College Dublin","ror":"https://ror.org/02tyrky19","country_code":"IE","type":"education","lineage":["https://openalex.org/I205274468"]}],"countries":["IE"],"is_corresponding":false,"raw_author_name":"Carsten Ehrhardt","raw_affiliation_strings":["Trinity College Dublin, Dublin 2, Ireland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Trinity College Dublin, Dublin 2, Ireland","institution_ids":["https://openalex.org/I205274468"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069886359","display_name":"Ben Forbes","orcid":"https://orcid.org/0000-0001-8193-6107","observed_orcids":["https://orcid.org/0000-0001-8193-6107"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ben Forbes","raw_affiliation_strings":["King\u2019s College London, London WC2R 2LS, U.K"],"raw_orcid":"https://orcid.org/0000-0001-8193-6107","affiliations":[{"raw_affiliation_string":"King\u2019s College London, London WC2R 2LS, U.K","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013254567","display_name":"Jayne E. Hastedt","orcid":"https://orcid.org/0000-0002-1784-4635","observed_orcids":["https://orcid.org/0000-0002-1784-4635"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jayne Hastedt","raw_affiliation_strings":["JDP Pharma Consulting, San Carlos, California 94070, United States"],"raw_orcid":"https://orcid.org/0000-0002-1784-4635","affiliations":[{"raw_affiliation_string":"JDP Pharma Consulting, San Carlos, California 94070, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071846305","display_name":"Anthony James Hickey","orcid":"https://orcid.org/0000-0002-3324-9326","observed_orcids":["https://orcid.org/0000-0002-3324-9326"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I180297670","display_name":"RTI International","ror":"https://ror.org/052tfza37","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I137902535","https://openalex.org/I170897317","https://openalex.org/I180297670"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anthony Hickey","raw_affiliation_strings":["RTI International, Research Triangle Park, North Carolina 27709, United States","University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"RTI International, Research Triangle Park, North Carolina 27709, United States","institution_ids":["https://openalex.org/I180297670"]},{"raw_affiliation_string":"University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033045204","display_name":"G\u00fcnther Hochhaus","orcid":"https://orcid.org/0000-0002-7406-5558","observed_orcids":["https://orcid.org/0000-0002-7406-5558"]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Guenther Hochhaus","raw_affiliation_strings":["University of Florida, Gainesville, Florida 32611, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Florida, Gainesville, Florida 32611, United States","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103049255","display_name":"Wenlei Jiang","orcid":"https://orcid.org/0009-0009-3876-638X","observed_orcids":["https://orcid.org/0009-0009-3876-638X"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wenlei Jiang","raw_affiliation_strings":["Center for Drug Evaluation and Research, Office of Generic Drugs, Office of Research and Standards, U.S. FDA, Silver Spring, Maryland 20993, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Drug Evaluation and Research, Office of Generic Drugs, Office of Research and Standards, U.S. FDA, Silver Spring, Maryland 20993, United States","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048430194","display_name":"Stavros C. Kassinos","orcid":"https://orcid.org/0000-0002-3501-3851","observed_orcids":["https://orcid.org/0000-0002-3501-3851"]},"institutions":[{"id":"https://openalex.org/I34771391","display_name":"University of Cyprus","ror":"https://ror.org/02qjrjx09","country_code":"CY","type":"education","lineage":["https://openalex.org/I34771391"]}],"countries":["CY"],"is_corresponding":false,"raw_author_name":"Stavros Kassinos","raw_affiliation_strings":["University of Cyprus, Nicosia 1678, Cyprus"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Cyprus, Nicosia 1678, Cyprus","institution_ids":["https://openalex.org/I34771391"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007070596","display_name":"Philip J. Kuehl","orcid":"https://orcid.org/0000-0002-7567-3002","observed_orcids":["https://orcid.org/0000-0002-7567-3002"]},"institutions":[{"id":"https://openalex.org/I4210131464","display_name":"Lovelace Medical Center","ror":"https://ror.org/02y4qch95","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210131464","https://openalex.org/I4210162315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Philip J. Kuehl","raw_affiliation_strings":["Lovelace Biomedical, Albuquerque, New Mexico 87108, United States"],"raw_orcid":"https://orcid.org/0000-0002-7567-3002","affiliations":[{"raw_affiliation_string":"Lovelace Biomedical, Albuquerque, New Mexico 87108, United States","institution_ids":["https://openalex.org/I4210131464"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026576726","display_name":"David Prime","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Prime","raw_affiliation_strings":["Pulmonary Drug Delivery Consultant, Ware SG12, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pulmonary Drug Delivery Consultant, Ware SG12, U.K","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030770558","display_name":"Yoen\u2010Ju Son","orcid":"https://orcid.org/0009-0002-5320-6937","observed_orcids":["https://orcid.org/0009-0002-5320-6937"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yoen-Ju Son","raw_affiliation_strings":["Genentech, South San Francisco, California 94080, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, South San Francisco, California 94080, United States","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113991795","display_name":"Simon J. Teague","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Simon P. Teague","raw_affiliation_strings":["GlaxoSmithKline, Stevenage SG1 2NY, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Stevenage SG1 2NY, U.K","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009707322","display_name":"Ulrika Tehler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Ulrika Tehler","raw_affiliation_strings":["Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Gothenburg 43183, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Gothenburg 43183, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"last","author":{"id":null,"display_name":"Jennifer Wylie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Wylie","raw_affiliation_strings":["Merck & Co., Inc., Kenilworth, New Jersey 07033, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Kenilworth, New Jersey 07033, United States","institution_ids":["https://openalex.org/I1285764155"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":15,"corresponding_author_ids":["https://openalex.org/A5081409383"],"corresponding_institution_ids":["https://openalex.org/I4210088933"],"apc_list":{"value":5000,"currency":"USD","value_usd":5000},"apc_paid":{"value":5000,"currency":"USD","value_usd":5000},"fwci":3.3851,"has_fulltext":false,"cited_by_count":25,"citation_normalized_percentile":{"value":0.93930168,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"19","issue":"7","first_page":"2040","last_page":"2047"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/inhaled-medications","display_name":"inhaled medications","score":0.9359999895095825},{"id":"https://openalex.org/keywords/biopharmaceutics-classification-system","display_name":"Biopharmaceutics Classification System","score":0.9039999842643738},{"id":"https://openalex.org/keywords/pulmonary-drug-absorption","display_name":"pulmonary drug absorption","score":0.7419999837875366},{"id":"https://openalex.org/keywords/effective-permeability","display_name":"effective permeability","score":0.8579999804496765},{"id":"https://openalex.org/keywords/dose-number","display_name":"dose number","score":0.8230000138282776},{"id":"https://openalex.org/keywords/dissolution","display_name":"dissolution","score":0.5249999761581421},{"id":"https://openalex.org/keywords/regional-lung-deposition","display_name":"regional lung deposition","score":0.9160000085830688}],"concepts":[{"id":"https://openalex.org/C2910701995","wikidata":"https://www.wikidata.org/wiki/Q679692","display_name":"Biopharmaceutics","level":5,"score":0.9240729212760925},{"id":"https://openalex.org/C2781430271","wikidata":"https://www.wikidata.org/wiki/Q278760","display_name":"Biopharmaceutics Classification System","level":3,"score":0.6742494702339172},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.547818660736084},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5040644407272339},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.491041898727417},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.44740110635757446},{"id":"https://openalex.org/C42404028","wikidata":"https://www.wikidata.org/wiki/Q864940","display_name":"Bioequivalence","level":3,"score":0.43709081411361694},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.36984992027282715},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.32573169469833374},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.09768566489219666},{"id":"https://openalex.org/C116073593","wikidata":"https://www.wikidata.org/wiki/Q864491","display_name":"Biological activity","level":3,"score":0.0},{"id":"https://openalex.org/C160492267","wikidata":"https://www.wikidata.org/wiki/Q319616","display_name":"Pharmacognosy","level":4,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D001702","descriptor_name":"Biopharmaceutics","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D007408","descriptor_name":"Intestinal Absorption","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D008168","descriptor_name":"Lung","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008954","descriptor_name":"Models, Biological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010539","descriptor_name":"Permeability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012995","descriptor_name":"Solubility","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1021/acs.molpharmaceut.2c00112","doi":"https://doi.org/10.1021/acs.molpharmaceut.2c00112","is_oa":true,"landing_page_url":"https://doi.org/10.1021/acs.molpharmaceut.2c00112","pdf_url":null,"source":{"id":"https://openalex.org/S204562082","display_name":"Molecular Pharmaceutics","issn_l":"1543-8384","issn":["1543-8384","1543-8392"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmaceutics","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9257747","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9257747","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mol Pharm","raw_type":"Text"},{"id":"pmid:35609877","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35609877","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular pharmaceutics","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1021/acs.molpharmaceut.2c00112","doi":"https://doi.org/10.1021/acs.molpharmaceut.2c00112","is_oa":true,"landing_page_url":"https://doi.org/10.1021/acs.molpharmaceut.2c00112","pdf_url":null,"source":{"id":"https://openalex.org/S204562082","display_name":"Molecular Pharmaceutics","issn_l":"1543-8384","issn":["1543-8384","1543-8392"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmaceutics","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.8371999859809875,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G268370915","display_name":null,"funder_award_id":"IP/2020/0959","funder_id":"https://openalex.org/F4320320834","funder_display_name":"Enterprise Ireland"},{"id":"https://openalex.org/G3293810002","display_name":null,"funder_award_id":"IP/2019/0797","funder_id":"https://openalex.org/F4320320834","funder_display_name":"Enterprise Ireland"},{"id":"https://openalex.org/G8082813225","display_name":null,"funder_award_id":"MP1404","funder_id":"https://openalex.org/F4320320366","funder_display_name":"European Cooperation in Science and Technology"}],"funders":[{"id":"https://openalex.org/F4320320366","display_name":"European Cooperation in Science and Technology","ror":"https://ror.org/01bstzn19"},{"id":"https://openalex.org/F4320320834","display_name":"Enterprise Ireland","ror":"https://ror.org/023z51242"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W59336656","https://openalex.org/W161165758","https://openalex.org/W1498305210","https://openalex.org/W1966640934","https://openalex.org/W1971574582","https://openalex.org/W1997820336","https://openalex.org/W2011765883","https://openalex.org/W2015979819","https://openalex.org/W2060728980","https://openalex.org/W2111225968","https://openalex.org/W2149383913","https://openalex.org/W2163787784","https://openalex.org/W2163894480","https://openalex.org/W2213477389","https://openalex.org/W2261610890","https://openalex.org/W2294689490","https://openalex.org/W2324532165","https://openalex.org/W2337691674","https://openalex.org/W2473682964","https://openalex.org/W2530860329","https://openalex.org/W2537023247","https://openalex.org/W2766963309","https://openalex.org/W2805914079","https://openalex.org/W3098999972","https://openalex.org/W3169276785","https://openalex.org/W4233212881","https://openalex.org/W4280514717","https://openalex.org/W4300642862"],"related_works":["https://openalex.org/W4389434864","https://openalex.org/W2294689490","https://openalex.org/W2112558196","https://openalex.org/W4408413775","https://openalex.org/W4280514717","https://openalex.org/W3122534602","https://openalex.org/W4391515246","https://openalex.org/W2033454953","https://openalex.org/W3158596281","https://openalex.org/W3127269481"],"abstract_inverted_index":{"High":[0],"Resolution":[1],"Image":[2],"Download":[3],"MS":[4],"PowerPoint":[5],"Slide":[6],"This":[7],"work":[8],"is":[9],"the":[10,18,47,50,92,171,192,203],"second":[11],"in":[12,69,101],"a":[13,25,38,146],"series":[14],"of":[15,24,49,95,173,186,194],"publications":[16],"outlining":[17],"fundamental":[19],"principles":[20],"and":[21,32,65,83,109,126,151,166,201],"proposed":[22],"design":[23,193],"biopharmaceutics":[26,52,197],"classifications":[27],"system":[28,199],"for":[29,205],"inhaled":[30,174],"drugs":[31,175,210],"drug":[33,67,148],"products":[34],"(the":[35],"iBCS).":[36],"Here,":[37],"mechanistic":[39],"computer-based":[40],"model":[41],"has":[42],"been":[43],"used":[44,163],"to":[45,75,99,191,202,208,212],"explore":[46],"sensitivity":[48,94],"primary":[51,96],"functional":[53,97],"output":[54],"parameters:":[55],"(i)":[56],"pulmonary":[57],"fraction":[58],"dose":[59,80],"absorbed":[60],"(":[61,71,86,120,128],"F":[62,129,152],"abs":[63,130,153],")":[64,74],"(ii)":[66],"half-life":[68],"lumen":[70,136],"t":[72,121],"1/2":[73,122],"biopharmaceutics-relevant":[76],"input":[77,161],"attributes":[78,162],"including":[79],"number":[81],"(Do)":[82],"effective":[84],"permeability":[85],"P":[87,110,167],"eff":[88,111],").":[89],"Results":[90],"show":[91,118],"nonlinear":[93],"outputs":[98],"variations":[100],"these":[102,187],"attributes.":[103],"Drugs":[104],"with":[105,179,189],"Do":[106,141,165],"<":[107,123],"1":[108,113],">":[112,131,142],"\u00d7":[114],"10":[115],"\u20136":[116],"cm/s":[117],"rapid":[119],"20":[124],"min)":[125],"complete":[127],"85%)":[132],"absorption":[133],"from":[134],"lung":[135,138,158],"into":[137,176],"tissue.":[139],"At":[140],"1,":[143],"dissolution":[144],"becomes":[145,154],"critical":[147],"product":[149],"attribute":[150],"dependent":[155],"on":[156],"regional":[157],"deposition.":[159],"The":[160,184],"here,":[164],"eff,":[168],"thus":[169],"enabled":[170],"classification":[172,198],"parameter":[177],"spaces":[178],"distinctly":[180],"different":[181],"biopharmaceutic":[182],"risks.":[183],"implications":[185],"findings":[188],"respect":[190],"an":[195],"inhalation-based":[196],"(iBCS)":[200],"need":[204,211],"experimental":[206],"methodologies":[207],"classify":[209],"be":[213],"further":[214],"explored.":[215]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2022-05-26T00:00:00"}